Epidemiology of Clostridioides difficile Infection in Long-Term Care Facilities

  • Syed Wasif Hussain
  • Muhammad Salman AshrafEmail author


Clostridioides difficile infection is one of the predominant causes of infectious diarrhea in elderly residents living in long-term care facilities. The epidemiology of C. difficile infection has changed significantly worldwide over the past two decades in all healthcare settings including nursing homes. In addition to describing the incidence and prevalence of C. difficile infection, this chapter focuses on strain diversity, colonization, and transmission of C. difficile in long-term care setting. A review of risk factors of C. difficile colonization and infection and mortality among nursing home residents due to this infection is also included.


Clostridioides difficile Epidemiology Long-term care facilities Incidence Prevalence Colonization Transmission Mortality Risk factors C. difficile strains 


  1. 1.
    Furuya-Kanamori L, et al. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 2015;15:516.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis. 2008;46:S4–11.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Khanna S, Pardi DS. Clostridium difficile infection: management strategies for a difficult disease. Ther Adv Gastroenterol. 2014;7(2):72–86.CrossRefGoogle Scholar
  4. 4.
    Migill SS, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med. 2014;370:1198–208.CrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. CDC. Accessed 23 Apr 2013.
  6. 6.
    Arvand M, et al. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS One. 2012;7(1):e30183.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Durham DP, et al. Quantifying transmission of Clostridium difficile within and outside healthcare settings. Emerg Infect Dis. 2016;22(4):608–16.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Lessa FC, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Chopra T, et al. Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial stewardship. Clin Infect Dis. 2015;60(S2):S72–6.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Yu H, et al. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. BMC Geriatr. 2016;16(1):193.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Ziakas PD, et al. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: a nationwide study. Medicine. 2016;95(31):e4187.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Freeman J, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529–49.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Zilberberg MD, et al. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000–2005. Emerg Infect Dis. 2008;14(6):929–31.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Archbald-Pannone LR, et al. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect. 2014;88(4):218–21.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Simor AE, et al. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 2002;23(11):696–703.CrossRefGoogle Scholar
  16. 16.
    Endres BT, et al. Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing. Infect Control Hosp Epidemiol. 2018;39:1322–9.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Luk S, et al. High prevalence and frequent acquisition of Clostridium difficile ribotype 002 among nursing home residents in Hong Kong. Infect Control Hosp Epidemiol. 2018;39(7):782–7.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Rodriguez, et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol. 2016;16:229.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Boone JH, et al. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis. 2012;31(7):1551–9.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    CDC. Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(13):340–3.Google Scholar
  21. 21.
    Joyce NR, et al. Effect of Clostridium difficile prevalence in hospitals and nursing homes on risk of infection. J Am Geriatr Soc. 2017;65:1527–34.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55(Suppl 2):S88–92.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Shashank G, et al. Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection. Dig Dis Sci. 2013;58:3407–12.CrossRefGoogle Scholar
  24. 24.
    Pawar D, et al. Burden of Clostridium difficile infection in long-term care facilities in Monroe County. New York. Infect Control Hosp Epidemiol. 2012;33:1107–12.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Kim JH, et al. Clostridium difficile Infection in a long-term care facility: hospital-associated illness compared with long-term care–associated illness. Infect Control Hosp Epidemiol. 2011;32(7):656–60.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Zarowitz BJ, et al. Risk factors, clinical characteristics, and treatment differences between residents with and without nursing home- and non-nursing home-acquired Clostridium difficile infection. J Manag Care Spec Pharm. 2015;21(7):585–95.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Laffan AM, et al. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc. 2006;54(7):1068–73.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    McDonald LC, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140–5.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Centers for Disease Control and Prevention. Laboratory-identified Multidrug-Resistant Organism (MDRO) & Clostridium difficile infection (CDI) events for long-term care facilities. CDC.
  30. 30.
    Ponnada SP, et al. Acquisition of Clostridium difficile colonization and infection after transfer from a veterans affairs hospital to an affiliated long-term care facility. Infect Control Hosp Epidemiol. 2017;38:1070–6.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Guerrero DM, et al. Clostridium difficile infection in a Department of Veterans Affairs long-term care facility. Infect Control Hosp Epidemiol. 2011;32:513–5.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Hunter JC, et al. Burden of nursing home onset Clostridium difficile infection in the United States: estimates of incidence and patient outcomes. Open Forum Infect Dis. 2016;3:ofv196.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Mylotte JM, et al. Surveillance for Clostridium difficile infection in nursing homes. J Am Geriatr Soc. 2013;61:122–5.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Centers for Disease Control and Prevention. The core elements of antibiotic stewardship for nursing homes. Available at: Accessed 8 Jun 2019.
  35. 35.
    Jump RLP, Donskey CJ. Clostridium difficile in the long-term care facility: prevention and management. Curr Geriatr Rep. 2015;4(1):60–9.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Monique JT, et al. Understanding Clostridium difficile colonization. Clin Microbiol Rev. 2018;31:e00021–17.Google Scholar
  37. 37.
    Ziakas PD, et al. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One. 2015;10(2):e0117195.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Schaffler H, Breitruck A. Clostridium difficile – from colonization to infection. Front Microbiol. 2018;9:646.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Loo VG, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693–703.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Jump RL, et al. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother. 2007;51(8):2883–7.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Dumford DM, et al. Epidemiology of Clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit. J Spinal Cord Med. 2011;34(1):22–7.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Vesteinsdottir I, et al. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis. 2012;31(10):2601–10.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Donskey CJ, et al. Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents. Infect Control Hosp Epidemiol. 2018;39(8):909–16.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Riggs MM, et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992–8.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Galdys AL, et al. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection. Expert Rev Anti-Infect Ther. 2014;12:967–80.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Curry SR, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57:1094–102.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Jinno S, et al. Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection. Infect Control Hosp Epidemiol. 2012;33(6):638–9.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Rodriguez C, et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014;30:184–7.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Sethi AK, et al. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol. 2010;31:21–7.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Kramer A, et al. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Quinn LK, et al. Infection control policies and practices for Iowa long-term care facility residents with Clostridium difficile infection. Infect Control Hosp Epidemiol. 2007;28(11):1228–32.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Ashraf MS, et al. Environmental cleaning and disinfection policies, protocols and practices: a survey of 27 long-term care facilities. Presented at SHEA 2018; April 18–20, 2018; Portland, OR. Abstract 10159 (Poster 214) Available at: Accessed 9 June 2019.
  53. 53.
    Nailon RE, et al. Impact of an audit and feedback program on environmental cleaning and disinfection in critical access hospitals and long-term care facilities. Presented at APIC 2018; June 13–15; Minneapolis, MN: American Journal of Infection Control, Volume 46, Issue 6, S29.Google Scholar
  54. 54.
    Van Schooneveld T. Survey of antimicrobial stewardship practices in Nebraska long-term care facilities. Infect Control Hosp Epidemiol. 2011;32(7):732–4.CrossRefGoogle Scholar
  55. 55.
    Lodhi HT, et al. Abstract 1838. Digging deeper: a closer look at core elements of antibiotic stewardship for long-term care facilities. Open Forum Infect Dis. 2018;5(Suppl 1):S524.PubMedCentralCrossRefGoogle Scholar
  56. 56.
    Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc. 2010;58:1556–64.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Al-Tureihi FI, et al. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. J Am Med Dir Assoc. 2005;6(2):105–8.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Haran JP, et al. Medication exposure and risk of recurrent Clostridium difficile infection in community-dwelling older people and nursing home residents. J Am Geriatr Soc. 2018;66(2):333–8.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Kings County HospitalBrooklynUSA
  2. 2.Suny Downstate Medical CenterBrooklynUSA
  3. 3.Division of Infectious Diseases, Department of Internal MedicineUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations